Join
Live feed
·
PRReleasevia Quantisnow
BioLineRx Ltd. logo

Hemispherian Announces USPTO Notice of Allowance for Key GLIX1 Patent Covering Majority of Solid Tumors

ByQuantisnow·Wall Street's wire, on your screen.
BLRX· BioLineRx Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BLRX (BioLineRx Ltd.) and more on Quantisnow.